Yiannis Kallis - Concepedia

Author

Yiannis Kallis

Queen Mary University of London ORCID

Also Known As

D Sa1510, Y Kallis, Y N Kallis, Y. Kallis, Y.N. Kallis, Yiannis Kallis, Yiannis N Kallis, Yiannis N. Kallis

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Queen Mary University of London University College London Imperial College London Glasgow Royal Infirmary University of Nottingham

About

Yiannis Kallis is an author at Queen Mary University of London specializing in medicine, pathology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	193
2	Cell Biology	2	2	41
3	Nursing	1	1	27
4	Public Health	1	1	27
5	Gastroenterology	1	1	125

Yiannis Kallis

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis Louise China, Nick Freemantle, Ewan Forrest, New England Journal of Medicine	2021	303
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis Gideon M. Hirschfield, Christopher L. Bowlus, Marlyn J. Mayo, New England Journal of Medicine	2024	192
Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit Yiannis Kallis, Natalie Phillips, Alan Steel, Digestive Diseases and Sciences Pancreatic CancerPancreatic Fluid CollectionEndoscopic Radiofrequency AblationPotential Survival BenefitMedicine	2015	125
Diagnostic and therapeutic utility of single-operator peroral cholangioscopy for indeterminate biliary lesions and bile duct stones Evangelos Kalaitzakis, George Webster, Kofi Oppong, European Journal of Gastroenterology & Hepatology	2012	120
Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response Yiannis Kallis, A. J. Robson, Jonathan Fallowfield, Gut	2010	107
Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk? Upkar S. Gill, Alexandra Zissimopoulos, Safa Al-Shamma, The Journal of Infectious Diseases	2014	95
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls Carla Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, Gastroenterology	2022	91
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis Nadir Abbas, Emma Culver, Douglas Thorburn, Clinical Gastroenterology and Hepatology	2022	34
The Royal Free Hospital ‘hub-and-spoke network model’ delivers effective care and increased access to liver transplantation David Tai, Anjan Dhar, Aileen Marshall, Public Health NursingHealth SystemsConnected HealthHospital EnvironmentOutcomes Research	2017	27
Proteinase Activated Receptor 1 Mediated Fibrosis in a Mouse Model of Liver Injury: A Role for Bone Marrow Derived Macrophages Yiannis Kallis, Christopher J. Scotton, Alison C. MacKinnon, PLoS ONE Liver FibrosisImmunologyCell DeathPathologyCirrhosis	2014	26

Page 1